A New Strategy of Cancer Immunotherapy Combining Hyperthermia/Oncolytic Virus Pretreatment with Specific Autologous Anti-Tumor Vaccination – A Review

@inproceedings{Volker2017ANS,
  title={A New Strategy of Cancer Immunotherapy Combining Hyperthermia/Oncolytic Virus Pretreatment with Specific Autologous Anti-Tumor Vaccination – A Review},
  author={Schirrmacher Volker},
  year={2017}
}
This review describes and explains a specific immunotherapy strategy that has been developed at the Immunological and Oncological Center Cologne in Germany. [...] Key Method The second step consists of active-specific autologous anti-tumor vaccination. The vaccine, VOL-DC, consists of autologous Dendritic Cells (DCs) which are loaded with Viral Oncolysate (VOL) from the patient’s tumor cells.Expand
Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
  • V. Schirrmacher
  • Biology, Medicine
  • International journal of molecular sciences
  • 2017
...
1
2
...

References

SHOWING 1-10 OF 52 REFERENCES
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
Cancer immunotherapy: Strategies for personalization and combinatorial approaches
Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.
Dendritic Cells Pulsed with Viral Oncolysate
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
An effective tumor vaccine optimized for costimulation via bispecific and trispecific fusion proteins.
...
1
2
3
4
5
...